The annual meeting of the American Academy of Orthopaedic Surgeons was held from March 10 to 14 in San Diego, drawing ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...